FR2448351A1 - Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc. - Google Patents

Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc.

Info

Publication number
FR2448351A1
FR2448351A1 FR7903920A FR7903920A FR2448351A1 FR 2448351 A1 FR2448351 A1 FR 2448351A1 FR 7903920 A FR7903920 A FR 7903920A FR 7903920 A FR7903920 A FR 7903920A FR 2448351 A1 FR2448351 A1 FR 2448351A1
Authority
FR
France
Prior art keywords
compsns
bacitracine
pectinase
contg
render
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7903920A
Other languages
French (fr)
Other versions
FR2448351B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7903920A priority Critical patent/FR2448351A1/en
Publication of FR2448351A1 publication Critical patent/FR2448351A1/en
Application granted granted Critical
Publication of FR2448351B1 publication Critical patent/FR2448351B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Compsns. contg. selected polysaccharases from bovine testicular hyaluronidase (I), Aspergillus niger purified pectinase (II), and bacitracine (III) are new. The compsns. cause detachment from their tissue support of bacteria fixed through polysaccharide fibres, and thus render them open to attach by curative agents, antiseptics, antibiotics, and the like. The compsns. are esp. useful in mouth washes and sublingual tablets.
FR7903920A 1979-02-09 1979-02-09 Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc. Granted FR2448351A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7903920A FR2448351A1 (en) 1979-02-09 1979-02-09 Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7903920A FR2448351A1 (en) 1979-02-09 1979-02-09 Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc.

Publications (2)

Publication Number Publication Date
FR2448351A1 true FR2448351A1 (en) 1980-09-05
FR2448351B1 FR2448351B1 (en) 1983-03-04

Family

ID=9222039

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7903920A Granted FR2448351A1 (en) 1979-02-09 1979-02-09 Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc.

Country Status (1)

Country Link
FR (1) FR2448351A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425016A2 (en) * 1989-10-27 1991-05-02 The Procter & Gamble Company Antimicrobial method and formulation employing type II endoglycosidase and antimicrobial agent
EP0425017A2 (en) * 1989-10-27 1991-05-02 The Procter & Gamble Company Method employing type II endoglycosidase
GB2327345A (en) * 1997-07-18 1999-01-27 Finnfeeds Int Ltd Use of a carbohydrase for controlling bacterial infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR11M (en) * 1960-05-12 1960-11-28 Albert Joulty Β-Diethylaminoethyl ether hydrochloride of 3,5-dibromo-2-methoxybenzyl alcohol.
FR3921M (en) * 1964-03-17 1966-02-14

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR11M (en) * 1960-05-12 1960-11-28 Albert Joulty Β-Diethylaminoethyl ether hydrochloride of 3,5-dibromo-2-methoxybenzyl alcohol.
FR3921M (en) * 1964-03-17 1966-02-14

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425016A2 (en) * 1989-10-27 1991-05-02 The Procter & Gamble Company Antimicrobial method and formulation employing type II endoglycosidase and antimicrobial agent
EP0425017A2 (en) * 1989-10-27 1991-05-02 The Procter & Gamble Company Method employing type II endoglycosidase
EP0425017A3 (en) * 1989-10-27 1991-10-02 The Procter & Gamble Company Method employing type ii endoglycosidase
EP0425016A3 (en) * 1989-10-27 1991-10-02 The Procter & Gamble Company Antimicrobial method and formulation employing type ii endoglycosidase and antimicrobial agent
US5258304A (en) * 1989-10-27 1993-11-02 Genencor International, Inc. Method of removing microorganisms from surfaces with Type II endoglycosidase
US5356803A (en) * 1989-10-27 1994-10-18 Genencor International, Inc. Antimicrobial composition containing Type II endoglycosidase and antimicrobial agent
GB2327345A (en) * 1997-07-18 1999-01-27 Finnfeeds Int Ltd Use of a carbohydrase for controlling bacterial infection
GB2327345B (en) * 1997-07-18 1999-06-23 Finnfeeds Int Ltd Use of an enzyme for manufacturing an agent for controlling bacterial infection
US7011964B2 (en) 1997-07-18 2006-03-14 Finnfeeds International Ltd. Use of an enzyme for the manufacture of an agent for controlling bacterial infection

Also Published As

Publication number Publication date
FR2448351B1 (en) 1983-03-04

Similar Documents

Publication Publication Date Title
AU7824987A (en) Aqueous polysaccharide compositions
DE3882398D1 (en) CONTACT GALLIUM ARSENIDE AND THEIR PRODUCTION PROCESS.
GR870073B (en) Non - powered analog telephone line transmitter system
DE3878340T2 (en) CRYSTALLINE L-CARNOSINE-ZINC COMPLEX AND THEIR PRODUCTION.
NZ220265A (en) Sterilised, concentrated milk product and production thereof
EP0126523A3 (en) Dentifrice compostions
ES8602841A1 (en) The aglycone and pseudo-aglycones of the AAD 216 antibiotics.
DE3780434T2 (en) REAR AXLE HOUSING AND THEIR PRODUCTION.
AU464024B2 (en) Improvements in or relating to bearing assemblies and bearing bushes therefor
ES481235A1 (en) 6-Chloro-2,3-dihydroxy-1,4-naphthoquinone and its 2,3-diesters, and their preparation.
FR2448351A1 (en) Compsns. contg. hyaluronidase, pectinase and bacitracine - cause bacterial detachment and render them more susceptible to antiseptics etc.
ES8404412A1 (en) Process for the production of rhamnose or fucose.
ES2051786T3 (en) GLYCOPEPTIDIC ANTIBIOTICS PA-45052.
AU3293993A (en) Cellulolytic, n2-fixing bacteria and use therefor
ES8802400A1 (en) Method and compositions for use in the treatment of fireblight.
JPS6468393A (en) Teichoplanine like derivative
AU6316386A (en) Kibdelosporangium aridum sk & f-aad-boo and production of antibiotic therefrom
CA2050946A1 (en) Use of polysaccharides in preparations for wound treatment
TR28110A (en) Using polyether ionophore antibiotics to control bacterial growth in sugar production.
AU4508189A (en) Improvements in or relating to ring spinning
ES8102138A1 (en) Cephalosporin derivatives
CA2068994A1 (en) Synchronous selective signalling system
ES8707251A1 (en) Antibiotics, their production and use.
GB1362108A (en) Process for preparing hydroxy-l-proline or n-acetyl-hydroxy- l-proline from hydrolysed gelatin
GB2208863B (en) Production of 2-methyl-5-isopropyl-hexa-2,5-dien-1-al and of 2-methyl-5-isopropyl-hexa-2,4-dien-1-al in microorganisms

Legal Events

Date Code Title Description
ST Notification of lapse